Abstract
1-(2-Pyrimidinyl)-4-imino-1,4-dihydropyridinium chloride, a hypoglycemie agent inhibits gluconeogenesis from lactate in the perfused guinea pig liver. The alterations in the concentrations of hepatic metabolites resemble those observed in the presence of phenylethylbiguanide and 1-methyl-4(3-methyl-5-isoxazolyl)-pyridinium chloride; reducing equivalents are increased while the ATP/ADP ratio and the hepatic cell respiration are decreased.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
